By getting to the root cause of patients’ allergies with detailed symptom histories from patients coupled with history, informed comprehensive allergy testing can help uncover hidden allergies, ensure both effective care and smarter resource utilization, and improve patient safety.
ARS Pharmaceuticals frames its intranasal epinephrine spray as a needle-free alternative to products such as EpiPen. Though this spray won the backing of an FDA advisory committee, the agency is now requiring that ARS Pharma run another study to support a regulatory submission.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap Medical wants to win a chunk of this fast-growing, $1.3 billion market.